镰状细胞病中体液免疫表型的改变
本研究比较了接受羟基脲治疗的儿童(n=13)和成人(n=12)镰状细胞病患者与种族匹配对照(儿童n=5,成人n=10)外周血中12种免疫细胞群频率及相关细胞因子水平,并对儿童患者和对照进行转录组分析。流式细胞术显示儿童镰状细胞病CD19+ B细胞增加3.5倍(p=0.005),成人镰状细胞病中央记忆B细胞减少52%(p=0.002)。儿童转录组数据显示前B细胞转录本(27个基因)和浆细胞转录本(37个基因)显著上调。
要点
- 儿童镰状细胞病CD19+ B细胞较对照增加3.5倍(p=0.005)。
- 成人镰状细胞病中央记忆B细胞较对照减少52%(p=0.002)。
- 儿童镰状细胞病IL-2、IL-4、TNFβ、IL-13和BAFF显著升高。
核心结论
- 数据表明儿童镰状细胞病体液免疫表型发生改变,特别是CD19+ B细胞增加,提示接受羟基脲治疗的镰状细胞病患儿体液免疫系统稳态可能存在显著改变。
研究设计与样本
- 研究比较了接受羟基脲处方的儿童(n=13)和成人(n=12)镰状细胞病患者与种族匹配的儿童(n=5)和成人(n=10)对照。
- 评估外周血中12种免疫细胞群频率及相关细胞因子水平,并对儿童镰状细胞病患者和对照进行外周血转录组分析。
主要发现
- 流式细胞术显示儿童镰状细胞病CD19+ B细胞较对照增加3.5倍(p=0.005)。
- 成人镰状细胞病中央记忆B细胞较对照减少52%(p=0.002)。
- 儿童转录组数据显示前B细胞转录本(27个基因,前3:E2F2、RAD51、ASPM)和浆细胞转录本(37个基因,前3:IGF1、TNFRSF17、DERL3)显著上调。
- 细胞因子分析显示儿童镰状细胞病IL-2(p=0.013)、IL-4(p=0.026)、TNFβ(p=0.039)、IL-13(p=0.034)和BAFF(p=0.041)显著增加,成人镰状细胞病CD40L和BAFF增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The pathophysiology of sickle cell disease (SCD) is linked to haemolysis and systemic inflammation. To determine the range of systemic alterations, we assessed the frequency of 12 immune populations and the levels of related cytokines in the peripheral blood of paediatric (n = 13) and adult (n = 12) patients with SCD prescribed hydroxyurea, as compared to paediatric (n = 5) and adult (n = 10) race-matched controls. Transcriptome analysis of the peripheral blood of paediatric SCD patients and controls was also performed. Flow cytometry showed a 3.5-fold increase (p = 0.005) in CD19+ B cells in paediatric SCD and a 52% decrease in central memory B cells (p = 0.002) in adult SCD. Paediatric transcriptomic data revealed significant upregulation of pro-B cell transcripts (27 genes, top 3: E2F2, RAD51, ASPM) and plasma cell transcripts (37 genes, top 3: IGF1, TNFRSF17, DERL3). Cytokine analyses showed significant increases in IL-2 (p = 0.013), IL-4 (p = 0.026), TNFβ (p = 0.039), IL-13 (p = 0.034) and BAFF (p = 0.041) in paediatric SCD, and an increase in CD40L and BAFF in adult SCD. In summary, our data showed alterations in the humoral immophenotype in paediatric SCD, specifically an increase in CD19+ B cells, suggesting there may be significant alterations of homeostasis in the humoral immune system in children with SCD treated with hydroxyurea.
引用
- Vistica Sampino E, Bonal DM, Chorzalska A, et al. Alterations in the humoral immunophenotype in sickle cell disease. Br J Haematol. 2025. PMID: 40368836. doi:10.1111/bjh.20089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。